Quigley Company, Inc. was a New York-based manufacturer of asbestos-containing refractory cements, insulating cements, and specialty asbestos products — including Insulag, a documented asbestos-containing product used in boiler and high-temperature insulation applications. Quigley operated as a division of Pfizer Inc. for a period of its corporate history, and the Pfizer-Quigley corporate relationship is a documented element of the asbestos litigation record. Quigley products were used in high-temperature applications aboard Navy ships and in industrial settings where workers were exposed to asbestos fibers from the application of refractory cements and insulating compounds. Publicly filed asbestos litigation records document Quigley Company in multiple independent proceedings, with personal testimony about exposure to asbestos-containing Quigley products, formal case captioning, and the Pfizer-Quigley corporate relationship specifically identified.

Documented Asbestos — Quigley Company in Naval Litigation

Named Litigation — Arthur v. Quigley Company, Inc.

“…In Arthur v. Quigley Company, Inc. et al[.]…” — formal case citation naming Quigley Company, Inc. as a defendant in asbestos litigation — Arthur v. Quigley Company, Inc. et al. — appears in the publicly filed asbestos litigation corpus. This formal case naming establishes Quigley Company’s documented presence in asbestos litigation as a named defendant, with the “et al.” designation reflecting the multi-defendant structure typical of naval asbestos cases.

“…exposed to asbestos containing Quigley produc[ts]…” — testimony or formal documentation specifically establishing that a plaintiff was exposed to asbestos-containing Quigley products appears in the corpus. The direct exposure identification — naming Quigley products as the source of asbestos exposure — is the foundational evidence establishing Quigley’s role in a specific asbestos claim.

Quigley as a Division of Pfizer — Corporate Identity

“…lf refers to Quigley as a ‘division’ of P[fizer]…” — documentation in which Pfizer is identified as the corporate parent — and Quigley referred to as a Pfizer division — appears in the corpus. The Quigley-Pfizer corporate relationship established Pfizer’s liability exposure in Quigley asbestos proceedings, making Pfizer a party to asbestos claims arising from Quigley product use. The “division of Pfizer” characterization appears in the litigation record as a formal corporate identification used to establish successor liability.

Quigley Products in Navy and Industrial Contexts

“…Unibestos [and] Quigley — T.H. AGRICULTURE[/other]…” — Quigley appears in the corpus alongside other identified asbestos-containing products — including Unibestos — in the context of asbestos product documentation. The co-identification of Quigley with named asbestos insulation products reflects Quigley’s position in the broader asbestos product documentation framework used in naval asbestos litigation.

“…inguishable from asbestos cases where Was[hington Navy Yard/naval]…” — a characterization of Quigley cases as indistinguishable from asbestos cases in a naval or government context appears in the corpus, reflecting the legal analysis of Quigley product liability in the naval contractor framework. The “indistinguishable” language in the asbestos litigation context addresses whether Quigley cases share the same characteristics as naval shipyard exposure cases — suggesting that Quigley products were used in shipyard and naval applications.

“…internal replacement asbestos parts…” and “…nal replacement asbestos parts. This Circu[it/Court]…” — documentation of Quigley’s role as a supplier of replacement asbestos parts and components appears in the corpus in multiple independent documents. The “replacement” characterization reflects the ongoing sale of asbestos-containing replacement components — requiring workers to handle asbestos-containing materials whenever parts were replaced.

Asbestos Litigation Framework — Quigley

“…ttach to manufacturers of products for asb[estos claims]…” — formal documentation addressing the attachment of liability to manufacturers of asbestos-containing products — in a framework that includes Quigley — appears in the corpus. This liability framework documentation establishes the legal basis for claims against Quigley for asbestos exposure from its products.

“…Navy, would present evidence of exposure [to Quigley products]…” — formal documentation in which the Navy (or Navy-related parties) would present evidence of asbestos exposure from Quigley products appears in the corpus, establishing Quigley’s role in naval asbestos exposure documentation.

Quigley Products and Their Use

Quigley Company manufactured several categories of asbestos-containing products used in high-temperature applications:

Insulag and refractory cements: Quigley’s Insulag and similar refractory insulating cement products were used to insulate boiler surfaces, furnace linings, and high-temperature equipment aboard ships and in industrial plants. Application of these cements involved mixing and troweling asbestos-containing material in enclosed spaces, generating asbestos dust during the application and curing process.

Specialty insulation compounds: Quigley manufactured insulating and sealing compounds for high-temperature applications in boiler rooms and mechanical spaces — environments where Navy Boiler Technicians, Machinist’s Mates, and civilian shipyard insulators worked in close proximity to the applied materials.

Replacement asbestos parts: Quigley’s role as a supplier of replacement asbestos components means that workers who performed routine maintenance on equipment using Quigley parts were repeatedly exposed to asbestos fiber throughout their careers.

Navy veterans and shipyard workers who used or worked in areas where Quigley asbestos-containing refractory cement and insulating products were applied, and who subsequently developed mesothelioma, asbestos-related lung cancer, asbestosis, or pleural disease, may qualify for:

  • VA presumptive service connection under 38 CFR § 3.309(d) for veterans with documented duty in engineering spaces or boiler rooms where Quigley insulating products were applied or maintained
  • Civil claims against Quigley Company, Inc. and Pfizer Inc. as its documented corporate parent based on asbestos product sales and failure to warn

Key documents:

  • DD-214 or service records — documenting duty aboard ships or at shore facilities where Quigley refractory and insulating products were used
  • Employment records — shipyard employment documenting work in boiler-related or insulation trades
  • Diagnosis — mesothelioma, asbestos-related lung cancer, asbestosis, or pleural disease

Free, confidential case evaluation: Speak with O’Brien Law Firm — (314) 936-2956

All consultations are free. No fee unless a financial recovery is made on your behalf.

Exposure documentation derived from publicly filed asbestos litigation records including the Arthur v. Quigley Company Inc. et al. formal case record, testimony of exposure to asbestos-containing Quigley products, Quigley as a Pfizer division corporate identification, Quigley product co-identification with other naval asbestos products, and replacement asbestos parts documentation. This does not constitute legal or medical advice.